On April 30, 2026 Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, reported its participation in the International Society for Cell & Gene Therapy (ISCT) 2026 Annual Meeting to be held in Dublin, Ireland from May 6-9, 2026. Factor will deliver an oral presentation on FACT-112, Factor’s IL12-expressing iMacrophage program for solid tumors.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"We are excited to share the latest pre-clinical data from our FACT-112 program at ISCT," said Dr. Matt Angel, Co-Founder, Chairman and CEO of Factor. "The striking anti-tumor activity of our engineered iMacrophages, demonstrated in vivo, represents a major milestone for the company, underscoring our commitment to translating cutting-edge science into clinically meaningful therapies."
Factor’s Associate Director of Cell Engineering, Ian Hay, who will deliver the presentation, added, "these data illustrate the intrinsic capacity of IL12-expressing iMacrophages to repolarize the immunosuppressive ovarian tumor microenvironment and elicit immune-mediated tumor rejection. We are excited about the potential to develop FACT-112 into a safe, effective option to patients with solid tumors."
Details of the oral presentation are below:
"iPSC-Derived Macrophages Engineered to Express IL-12 Modulate the Tumor Microenvironment and Support T Cell Lysis of Ovarian Cancer Models" -to be presented by Ian Hay on Wednesday, May 6 from 1:00-2:00 pm GMT, in the Immunotherapy Oral Presentation Session.
For more information about the International Society for Cell & Gene Therapy (ISCT) 2026 Annual Meeting, visit www.isctglobal.org/annual-meeting.
(Press release, Factor Bioscience, APR 30, 2026, View Source [SID1234664983])